Pharmaceutical Manufacturers or Contract Manufacturing

eck progress, including isolation and genetic mapping of a new SARS virus, that may, under the right circumstances, lay the groundwork for new treatments. Pharmaceutical companies are publicly sceptical about acknowledging the financial potential that a SARS drug and vaccine may offer. Privately they are busy committing large sums to SARS research. Shouldn't you be part of this potential market?